Ashibio
Latest round
- Series A
Last raised
- Mar 2024
Total raised
- $29M
Investors
- 4
About Ashibio
's focus is the research and development of novel therapies for rare bone and connective tissue diseases. In June 2024, Ashibio, Inc. Ashibio is engaged in the advanced development of several investigative therapies, including a potential treatment for fibrodysplasia ossificans progressiva (FOP), a rare genetic disease characterized by severe and progressive heterotopic ossification (HO), a pathological condition that causes abnormal bone formation in muscles, tendons, ligaments, and other soft tissues.
Who invested in Ashibio
4 investors across 1 round
See all investors in Ashibio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 28, 2024
Amount
$29M
Investors
Questions about Ashibio
Who invested in Ashibio?
Ashibio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ashibio raised?
Ashibio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ashibio last raise money?
Ashibio's most recent round on record is a Series A, in Mar 2024.
What does Ashibio do?
's focus is the research and development of novel therapies for rare bone and connective tissue diseases.
Where is Ashibio headquartered?
Ashibio is headquartered in Brisbane, US.
Which VCs invest in companies like Ashibio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ashibio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ashibio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.